131 related articles for article (PubMed ID: 3216522)
41. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
[TBL] [Abstract][Full Text] [Related]
42. Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal.
Breccia M; Latagliata R; Cannella L; Carmosino I; De Cuia R; Frustaci A; Stefanizzi C; Santopietro M; Alimena G
Leuk Res; 2009 Mar; 33(3):391-4. PubMed ID: 18676015
[TBL] [Abstract][Full Text] [Related]
43. A cytochemical note on nucleoli of granulocytic precursors and granulocytes in patients suffering from the refractory anemia with excess blasts (RAEB) of the myelodysplastic syndrome (MDS).
Smetana K; Jirásková I; Malasková V; Cermák J
Neoplasma; 2002; 49(1):5-9. PubMed ID: 12044061
[TBL] [Abstract][Full Text] [Related]
44. Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts.
Oguma S; Yoshida Y; Uchino H; Maekawa T
Cancer Res; 1987 Jul; 47(13):3599-602. PubMed ID: 3581090
[TBL] [Abstract][Full Text] [Related]
45. [Refractory anemia with excess of blasts in transformation induced by thorotrast].
Haruyama H; Fujita N; Shimazaki C; Nakanishi S; Sugishima K; Nakagawa M; Ijichi H; Taniwaki M; Kitamura T; Mori T
Rinsho Ketsueki; 1988 Jun; 29(6):840-4. PubMed ID: 3166495
[No Abstract] [Full Text] [Related]
46. [Refractory anemia with excess of blasts in transformation (RAEB-t)].
Yoshida Y
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):198-200. PubMed ID: 9851120
[No Abstract] [Full Text] [Related]
47. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?
Wong KF; Chan JK
Br J Haematol; 1991 Apr; 77(4):509-14. PubMed ID: 2025576
[TBL] [Abstract][Full Text] [Related]
48. [Clinicopathological study of myelodysplastic syndrome].
Ohnishi Y; Nemoto K
Rinsho Ketsueki; 1986 Sep; 27(9):1773-9. PubMed ID: 3806986
[No Abstract] [Full Text] [Related]
49. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
50. [Refractory anemia with excess of blasts in transformation with heritable fragile site: a case report].
Nagashima M; Suzuki J; Aoyama A; Tsuji M; Bessho M; Saito M; Hirashima K; Minamihisamatsu M
Rinsho Ketsueki; 1988 Feb; 29(2):243-8. PubMed ID: 3385947
[No Abstract] [Full Text] [Related]
51. [Chronic myelomonocytic leukemia evolved from refractory anemia with excess of blasts, associated with karyotypic abnormality and marked monocytosis].
Kadowaki N; Kamesaki H; Ohno Y; Amano H; Imanaka T; Takahashi Y; Kobashi Y
Rinsho Ketsueki; 1988 Nov; 29(11):2145-51. PubMed ID: 3070078
[No Abstract] [Full Text] [Related]
52. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
Perez A; Kennedy C; Standen G; Oxley J
Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
[TBL] [Abstract][Full Text] [Related]
53. Multinucleate megakaryocytes in refractory anemia with excess blasts.
Wheeler LA; Hogan RP; Schwenk GR; Griep JA
Arch Pathol Lab Med; 1983 May; 107(5):277-8. PubMed ID: 6687675
[No Abstract] [Full Text] [Related]
54. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts.
Koca E; Buyukasik Y; Cetiner D; Yilmaz R; Sayinalp N; Yasavul U; Uner A
Leuk Res; 2008 Mar; 32(3):495-9. PubMed ID: 17706281
[TBL] [Abstract][Full Text] [Related]
55. Varying probability of the development of acute nonlymphoblastic leukemia in refractory anemia patients with an excess of blasts.
Oguma S; Yoshida Y; Uchino H; Maekawa T
Cancer Res; 1987 Apr; 47(8):2196-8. PubMed ID: 3829004
[TBL] [Abstract][Full Text] [Related]
56. A quantitative analysis of the human bone marrow granulocytic cell lineage using the SAMBA 200 cell image processor. II. The blast cells in refractory anemia with an excess of blasts.
Seigneurin D; Brugal G; Payard D; Gauvain C
Anal Quant Cytol Histol; 1986 Dec; 8(4):281-92. PubMed ID: 3814295
[TBL] [Abstract][Full Text] [Related]
57. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
58. [Autoimmune hemolytic anemia in a case of refractory anemia with excess of blasts].
Oshima S; Kawano F; Nakai R; Takatsuki K; Nishimura Y; Fujiwara H; Seno T; Yamaguchi H
Rinsho Ketsueki; 1986 Mar; 27(3):381-5. PubMed ID: 3735687
[No Abstract] [Full Text] [Related]
59. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
[TBL] [Abstract][Full Text] [Related]
60. [A case of acute myelogenous leukemia accompanied with myelofibrosis and megakaryocyte-like giant bizarre blasts].
Yasunaga M; Hodohara K; Bamba F; Kitamura K; Fukuda M; Boku T; Miyagawa A; Inoue T; Kitoh K; Andoh A
Rinsho Byori; 1995 Oct; 43(10):1078-82. PubMed ID: 8531394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
